Comparative efficacy and toxicity of (177)Lu- vs (90)Y-theranostic anti-HER2/anti-DOTA(metal) pretargeted radioimmunotherapy (anti-HER2 DOTA-PRIT) of HER2-expressing breast cancer xenografts with curative intent Meeting Abstract


Authors: Cheal, S.; Fung, E.; Xu, H.; Guo, H. F.; Patel, M.; Bell, M.; Kalidindi, T.; Punzalan, B.; Zanzonico, P.; Wittrup, K.; Larson, S.; Cheung, N. K.
Abstract Title: Comparative efficacy and toxicity of (177)Lu- vs (90)Y-theranostic anti-HER2/anti-DOTA(metal) pretargeted radioimmunotherapy (anti-HER2 DOTA-PRIT) of HER2-expressing breast cancer xenografts with curative intent
Meeting Title: 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)
Journal Title: Journal of Nuclear Medicine
Volume: 58
Issue: Suppl. 1
Meeting Dates: 2017 Jun 10-14
Meeting Location: Denver, CO
ISSN: 0161-5505
Publisher: Society of Nuclear Medicine  
Date Published: 2017-05-01
Start Page: 54
Language: English
ACCESSION: WOS:000404949900055
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos